WESTBOROUGH, MA--(MARKET WIRE)--Aug 23, 2007 -- IBC announced today that its Drug Discovery & Development of Innovative Therapeutics India will feature two conference tracks: "Discovery to Innovation" and "Clinical Trials in India." Each track will include case studies from Western companies who have operations in India or have developed successful partnerships, such as AstraZeneca, Targacept, and Pfizer. "Clinical Trials in India" is a new addition to the program this year.
